Park Circle Company’s CVS Health CVS Stock Holding History

Park Circle Company’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-10,000	Closed	-$683K	–	101
2020 Q4	$683K	Buy	+10,000	New	+$650K	0.65%	34

Other funds holding CVS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Park Circle Company's CVS Position: Q4 2025 in Review

Park Circle Company sold out of CVS Health (CVS) in Q4 2025, closing a stake of 600 shares — an estimated $45.2K sold.

Park Circle Company first reported a position in CVS in Q1 2019 and held it in 27 quarters. The position peaked at $72K in Q4 2021. 1,945 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

Park Circle Company reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
Park Circle Company sold 600 CVS Health shares in Q4 2025, an estimated $45.2K.
Park Circle Company first reported a position in CVS Health in Q1 2019 and held it in 27 quarters.
Park Circle Company's CVS Health position peaked at $72K in Q4 2021.
1,945 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Park Circle Company's 13F filing for Q4 2025, filed 13 Feb 2026.